Quantifying Tertiary Lymphoid Structures in Resected Pancreatic Ductal Adenocarcinoma in Clinical Practice - A Feasibility Study Demonstrating a Correlation with Survival

Authors

Brian K. Theisen, Henry Ford HealthFollow
Madison George, Henry Ford HealthFollow
Ian Loveless, Henry Ford HealthFollow
Nina Steele, Henry Ford HealthFollow

Recommended Citation

Theisen BK, George M, Loveless I, Steele N. Quantifying Tertiary Lymphoid Structures in Resected Pancreatic Ductal Adenocarcinoma in Clinical Practice - A Feasibility Study Demonstrating a Correlation with Survival. Lab Invest 2024; 104(3):S1862-S1863.

Document Type

Conference Proceeding

Publication Date

3-28-2024

Publication Title

Lab Invest

Volume

104

Issue

3

First Page

S1862

Last Page

S1863